Trans American Aquaculture (GRPS) Capital Expenditures (2023 - 2024)
Trans American Aquaculture (GRPS) reported Capital Expenditures of -$6.7 million for Q4 2024, down 55187.66% quarter-over-quarter from $12216.0 in Q1 2024.
Trans American Aquaculture (GRPS) Capital Expenditures (2023 - 2024) Analysis & Trends
Trans American Aquaculture has reported Capital Expenditures for 2 years, with the latest figure at -$6.7 million in Q4 2024.
- For the quarter ending Q4 2024, Capital Expenditures changed N/A year-over-year to -$6.7 million; the trailing twelve-month figure through Sep 2025 stood at -$6.7 million (down 55187.66% YoY), and the FY2024 full-year result was -$6.7 million, down 44491.3% from the prior year.
- Capital Expenditures for Q4 2024 stood at -$6.7 million, down from $12216.0 in the prior quarter.
- The five-year high for Capital Expenditures was $15132.0 in Q1 2023, with the low at -$6.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 2.04 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 8.83 Mn |
| 10 | Trans American Aquaculture | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -6.73 Mn |
| Dec 31, 2024 | -6.73 Mn |
| Mar 31, 2024 | 12,216.00 |
| Mar 31, 2024 | 12,216.00 |
| Mar 31, 2023 | 15,132.00 |
| Mar 31, 2023 | 15,132.00 |